A randomized, multicenter, parallel-group, Phase III study to compare the efficacy of arfolitixorin versus leucovorin in combination with 5-fluorouracil, oxaliplatin, and bevacizumab in patients with advanced colorectal cancer

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/57050/MH-2019
NMA SSA Reference Number: SSA/57050/MonH-2019-189953(v1)
Monash Health Ref: RES-19-0000-759X
Effective start/end date20/11/1919/11/24


  • clinical trial
  • treatment efficacy
  • phase 3 study
  • colorectal cancer